• Parkinson’s Research

  Study: AV-101 Reduced Dyskinesia Without Amantadine’s Side Effects

  Posted by Community Member on July 9, 2019 at 11:11 am

  

  Click here to read about the results of VistaGen Therapeutics’ candidate AV-101 in a non-human primate model of Parkinson’s disease.

  What do you think about this news?

  replied 7 years ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply